President Trump has announced a new tariff plan for imported generic drugs designed to bring production to the United States, which would hopefully lower prices and eliminate some money stress for consumers. However, the generic drug industry is pushing back and pointing out potential issues with the plan that might affect production.
If you or a loved one depend on an imported generic drug, here's what to know about how the plan is supposed to work and what to expect.
Get instant access to hundreds of discounts
Over 50? Join AARP today— because if you’re not a member you could be missing out on huge perks like discounts on travel, dining, and even prescriptions.
Get 25% off membership — just $15 for your first year with auto-renewal — and a free gift if you join today.
The timeline of Trump's generic drug tariff plan
In an effort to shift generic drug production to the United States, Trump has announced a policy that would implement tariffs on imported generic drugs. According to Trump, the tariffs wouldn't go into effect for two years, giving manufacturers the opportunity to transition manufacturing to the U.S.
After two years, tariffs of 100% would be placed on imported generic drugs for one year. At the end of the year, those tariffs would then increase to 200%. The Trump administration reports that the tariffs should help bring pharmaceutical production back to the U.S.
At this time, since tariffs aren't yet implemented, nothing should change at the pharmacy.
Why tariffs for imported generic drugs matter
Generic drugs account for about 90% of U.S. prescriptions, and India supplies nearly half of all of the generic drugs taken in the U.S. These generic medications save U.S. consumers billions in health care costs, and in 2022, the savings from Indian generic drugs alone amounted to $219 billion.
Since generic drug prices are so low, manufacturers of the medications often compete against each other. That fierce competition leaves little room for the manufacturers to absorb any price increases. If tariffs drive up production costs, then drug prices must increase, margins must decrease, or manufacturers might choose not to produce certain products. It's possible that shortages on these medications might occur if a transition to U.S. production lags.
Additionally, building a drug manufacturing system in the U.S. takes at least four to five years, meaning there simply might not be time for manufacturers to transition and implement manufacturing onshore.
How generic drug tariffs might impact the health care system
These tariffs on imported generic drugs could potentially impact the entire health care system. If manufacturers must substantially increase the price of generic drugs because of the cost of bringing production to the U.S., those higher costs might eventually work their way through the greater health care system. Since 90% of generic drugs are imported to the U.S., the tariffs would effectively impact nearly all manufacturers, and the effect of such tariffs could be widespread.
President Trump campaigned on increasing affordability, including reducing drug costs. If the tariffs actually increase the cost of generic drugs, that shift might undermine his campaigning message.
Resolve $10,000 or more of your debt
National Debt Relief could help you resolve your credit card debt with an affordable plan that works for you. Just tell them your situation, then find out your debt relief options.1 <p>Clients who complete the program and settle all debts typically save around 45% before fees or 20% including fees over 24–48 months, based on enrolled debts. “Debt-free” applies only to enrolled credit cards, personal loans, and medical bills. Not mortgages, car loans, or other debts. Average program completion time is 24–48 months; not all debts are eligible, and results vary as not all clients complete the program due to factors like insufficient savings. We do not guarantee specific debt reductions or timelines, nor do we assume debt, make payments to creditors, or offer legal, tax, bankruptcy, or credit repair services. Consult a tax professional or attorney as needed. Services are not available in all states. Participation may adversely affect your credit rating or score. Nonpayment of debt may result in increased finance and other charges, collection efforts, or litigation. Read all program materials before enrolling. National Debt Relief’s fees are based on a percentage of enrolled debt. All communications may be recorded or monitored for quality assurance. In certain states, additional disclosures and licensing apply. ©️ 2009–2025 National Debt Relief LLC. National Debt Relief (NMLS #1250950, CA CFL Lic. No. 60DBO-70443) is located at 180 Maiden Lane, 28th Floor, New York, NY 10038. All rights reserved. <b><a href="https://www.nationaldebtrelief.com/licenses/">Click here</a></b> for additional state-specific disclosures and licensing information.</p>
Sign up for a free debt assessment here.
The patients who are most at risk because of tariffs on generic drugs
The potential consequences of tariffs on generic drugs put certain patients at risk. An IQVIA study revealed that more than 60% of hypertension and mental health prescriptions in the U.S. are filled with Indian-made drugs, indicating the U.S. is highly dependent on imported generic medications for certain health conditions. Consumers who take medications for such health conditions might feel the impacts of these tariffs the most strongly.
If the tariffs drive up the price of generic medications, then U.S. consumers who are already on tight budgets might be strongly affected. It's possible that some consumers might not be able to afford their medications if prices increase, and they might be forced to go without them. Americans who are enrolled in high-deductible plans may be significantly impacted, as could those who are on Medicare or Medicaid plans.
How Chinese tariffs are affecting U.S. drug production
This isn't the first time that Trump's tariffs have affected medication prices in the U.S. The majority of the raw materials required to manufacture prescription drugs in the U.S. are located outside of the country, and China fulfills about 40% of the global supply of such raw materials. Since Trump took office, tariffs on Chinese imports have increased 20%, driving up the cost of the raw materials that U.S. drugmakers need.
Bottom line
At this time, Trump's tariff plan is an announced policy and is not a settled law. There's already been pushback among manufacturers and industry representatives, and how the tariffs affect manufacturing and prices partially depends on how the administration implements the policy. For example, if the administration only requires manufacturers to demonstrate that efforts are underway to manufacture drugs in the U.S., more manufacturers may be able to meet the two-year timeline and avoid the tariffs.
There's no need to take action now, since the potential effects of the policy are still two years away. As the tariff deadline nears, it may be a good idea to ask your pharmacist about any potential supply disruptions of medications that you take. If price increases are anticipated, give some thought to how you might cope with increasing bills so you're prepared for the cost.
More from FinanceBuzz:
- Retire like the rich: 14 ways you could build wealth in your 50s.
- Find out if you could pay less for car insurance in just a few clicks.
- Make these 7 savvy moves when you have $1,000 in the bank.
- 14 moves seniors could benefit from but often forget about.
Add Us On Google